Concept Life Sciences Holdings Ltd.. (1/18/18). "Press Release: Concept Life Sciences and Alderley Analytical Partner to Provide Bioanalytical and DMPK Services". Manchester.

	Organisation	Concept Life Sciences, Manchester
	Group	Spectris (Group)
	Organisation 2	Alderley Analytical Ltd.
	Product	analytical services
	Product 2	ADME services
	Index term	Concept Life Sciences–Alderley Analytical: analytical services, 201801– collab partnership to provide bioanalytical + DMPK services
	Person	Fort, Michael (Concept Life Sciences 201708 Executive Chairman)
	Person 2	Thomas, Elisabeth (Liz) (Alderley Analytical 201801 CEO)

Concept Life Sciences (“Concept”), the integrated drug discovery, development and analytical services company, and Alderley Analytical, the GLP/GCP compliant, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.

Under the terms of the agreement, Concept will gain access to Alderley Analytical’s significant expertise in bioanalysis, and Alderley Analytical will benefit from Concept’s deep understanding of synthetic, organic and medicinal chemistry, biology, toxicology, and analytical services. The combined offering will give clients of both companies, including biotech, pharma and agrochemicals companies, access to industry-leading assay development services for quantification of new molecules in a biological matrix, using the most sensitive instrumentation available.

Michael Fort, Executive Chairman, Concept Life Sciences, commented: “The team at Alderley Analytical has built an impressive reputation for delivery of the highest quality GLP/GCP bioanalytical services. Combining this offering with our Group’s expertise, including the recent additions of translational biology and large molecule research, brings benefits to the widest group of life sciences clients.”

Liz Thomas, CEO, Alderley Analytical, said: “We are delighted to be partnering with Concept Life Sciences group at this stage in our company’s development. Concept’s size, business development network and complementary scientific capability will make the enhanced service offering highly attractive and beneficial to a wide group of national and international clients.’’

ENDS

Media contacts

For Concept Life Sciences

Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0)7787 502 947

For Alderley Analytical
Elizabeth Thomas
E: elizabeth.thomas@alderleyanalytical.com
T: +44 (0) 7710 658068

About Concept Life Sciences
www.conceptlifesciences.com

Concept Life Sciences provides integrated, high quality drug discovery, development and analytical services to the life science sector. Formed as a result of targeted acquisition and organic growth, the Company has the in-house expertise and resource to support customers with projects spanning from target discovery to the clinic, adding value and IP throughout the discovery pathway.

With a track record of delivering knowledge-based, science-led solutions, the Company employs over 700 FTEs, including more than 500 highly skilled, experienced scientists, supporting its global client base from 11 state of the art laboratory facilities.

Concept Life Sciences has worked with all of the top 10 pharma and biotech companies, and is targeting revenues exceeding $60m in 2017. Having experienced rapid growth, the Company remains focused on problem solving, quality, collaboration, and flexibility.

Concept Life Sciences was formed in 2014 with backing from private equity firm Equistone Partners Europe.

About Alderley Analytical
https://alderleyanalytical.com/

Alderley Analytical is a GLP/GCP compliant, bioanalytical Contract Research Organisation (CRO), based at Alderley Park in Cheshire. Alderley Analytical offers independent bioanalytical services to support discovery, pre-clinical and clinical projects.

Alderley Analytical clients include high growth and established biotech, pharma and CRO’s around the world who appreciate a bespoke tailored service and consultative approach. The scientific management team have experienced life in large pharmaceutical companies and CRO’s and ensures that all clients receive the same, high quality service, irrespective of size. The management team also understand the pressure to deliver critically important programmes and take the time to listen and understand the project objectives, then offer innovative solutions.

Record changed: 2023-06-05